Dirui Industrial Co (300396) Q3 2025 earnings summary

Executive summary

• Revenue and net profit declined sharply year-over-year, with net profit down over 145% for the nine-month period due to domestic market pressures and price adjustments in key product lines.

• Management restructured the board and executive team, focusing on industrial operations and international market expansion.

• R&D efforts were realigned to support digital and intelligent healthcare initiatives, especially for strategic shareholders.

Financial highlights

• Revenue for the third quarter was ¥118.06 million, down 60.27% year-over-year; nine-month revenue was ¥468.75 million, down 60.12%.

• Net profit attributable to shareholders was -¥58.94 million for the quarter and -¥87.25 million for the nine months, down 315.63% and 145.31% year-over-year, respectively.

• Basic and diluted EPS for the nine months was -0.32, down 145.31% year-over-year.

• Total assets at quarter-end were ¥2.78 billion, down 10.38% from the previous year-end.

• Owner's equity attributable to shareholders was ¥1.90 billion, down 7.47% from year-end.

Outlook and guidance

• Management expects short-term sales and profit pressure to persist due to domestic market competition and price adjustments but is implementing a 100-day campaign to drive performance in Q4.

• International market expansion and local policy adaptation remain key growth drivers.